Peil, J.; Bock, F.; Kiefer, F.; Schmidt, R.; Heindl, L.M.; Cursiefen, C.; Schlereth, S.L.
New Therapeutic Approaches for Conjunctival Melanoma—What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells. Int. J. Mol. Sci. 2022, 23, 1478.
https://doi.org/10.3390/ijms23031478
AMA Style
Peil J, Bock F, Kiefer F, Schmidt R, Heindl LM, Cursiefen C, Schlereth SL.
New Therapeutic Approaches for Conjunctival Melanoma—What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells. International Journal of Molecular Sciences. 2022; 23(3):1478.
https://doi.org/10.3390/ijms23031478
Chicago/Turabian Style
Peil, Jennifer, Felix Bock, Friedemann Kiefer, Rebecca Schmidt, Ludwig M. Heindl, Claus Cursiefen, and Simona L. Schlereth.
2022. "New Therapeutic Approaches for Conjunctival Melanoma—What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells" International Journal of Molecular Sciences 23, no. 3: 1478.
https://doi.org/10.3390/ijms23031478
APA Style
Peil, J., Bock, F., Kiefer, F., Schmidt, R., Heindl, L. M., Cursiefen, C., & Schlereth, S. L.
(2022). New Therapeutic Approaches for Conjunctival Melanoma—What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells. International Journal of Molecular Sciences, 23(3), 1478.
https://doi.org/10.3390/ijms23031478
